What is the difference between gabapentin and pregabalin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Key Differences Between Gabapentin and Pregabalin

Pregabalin offers more predictable pharmacokinetics with linear absorption and requires lower total daily doses (maximum 600 mg/day vs 3600 mg/day for gabapentin), making it easier to dose, though gabapentin is typically less expensive and both medications have similar efficacy and side effect profiles for neuropathic pain. 1, 2

Pharmacokinetic Differences

The most clinically significant difference lies in how these medications are absorbed:

  • Gabapentin has saturable, nonlinear absorption that decreases as doses increase—bioavailability drops from 60% at 900 mg/day to only 33% at 3600 mg/day, with peak concentrations reached in 3-4 hours 3
  • Pregabalin has linear, predictable absorption maintaining ≥90% bioavailability regardless of dose, with peak concentrations achieved within 1 hour 3
  • This means pregabalin plasma concentrations increase proportionally with dose increases, while gabapentin does not 1, 3

Dosing Differences

Maximum daily doses differ substantially:

  • Gabapentin: 3600 mg/day divided into 3 doses 1, 2
  • Pregabalin: 600 mg/day divided into 2-3 doses 1, 2

Starting doses:

  • Gabapentin: 100-300 mg at bedtime or three times daily 1
  • Pregabalin: 50 mg three times daily or 75 mg twice daily 1, 2

The equianalgesic relationship suggests 30 mg of mirogabalin equals 600 mg pregabalin and over 1200 mg gabapentin, indicating pregabalin requires roughly half the dose of gabapentin for similar effects 4

Shared Characteristics

Both medications work identically by binding to voltage-gated calcium channels at the α2δ subunit, inhibiting excitatory neurotransmitter release 5, 1

Common side effects for both include:

  • Dose-dependent dizziness and somnolence 1, 2
  • Dry mouth and constipation 1, 2
  • Weight gain and peripheral edema, particularly in elderly patients 1, 2, 6

Both medications:

  • Are eliminated unchanged renally with ~6 hour half-lives, requiring dose adjustment in renal impairment 6, 3
  • Do not bind to plasma proteins 3
  • Are not metabolized by hepatic enzymes and have minimal drug-drug interactions 6, 3
  • Should never be discontinued abruptly—taper gradually to avoid withdrawal 1

Clinical Efficacy

For neuropathic pain, pregabalin 450 mg/day appears to reduce pain comparably to the predicted maximum effect of gabapentin 3. However, higher pregabalin doses above 300 mg/day are not consistently more effective and increase adverse effects 1. Both are considered first-line anticonvulsants for neuropathic pain (except trigeminal neuralgia) 5.

Practical Considerations

Cost typically favors gabapentin, as generic formulations are less expensive than pregabalin 1

Pregabalin may be better tolerated overall due to its superior adverse event profile compared to alternatives like amitriptyline 1

For elderly or medically frail patients, both require lower starting doses and slower titration (dose increments of 50-100% every few days) 1, 2

Critical Pitfall

Never prescribe gabapentin and pregabalin together—this represents therapeutic duplication that can cause severe drowsiness, dizziness, fatigue, and ataxia without additional benefit 7. While some sources mention potential synergistic effects 8, the risk of adverse effects from combining these mechanistically identical medications outweighs theoretical benefits in routine practice 7.

References

Guideline

Gabapentin vs. Pregabalin for Neuropathic Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pregabalin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pregabalin: new drug. Very similar to gabapentin.

Prescrire international, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.